Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial
Shijun Xia, Xueyuan Guo, Xin Du, Changsheng Ma et al.
Citations
1 citations
Journal
Circulation
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
1.39
article
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial
Shijun Xia, Xueyuan Guo, Xin Du, Changsheng Ma, Caihua Sang, Song Zuo, Chao Jiang, Hang Guo, Zixu Zhao, Deyong Long, Laurent Macle, Chenxi Jiang, Wenli Dai, Paul C. Zei, Junmeng Zhang, Jianzeng Dong, Xiangyi Kong, Hui Xu, Ribo Tang, Songnan Li, Zejun Yang, Chi Wang, Nian Liu, Xiaoxia Liu, Ning Zhou, Xu Yang, Liu He, Yiping Wang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 153(5)
Institutions
University of Iowa (US), Brigham and Women's Hospital (US), Harvard University (US), Capital Medical University (CN), Montreal Heart Institute (CA), Beijing Anzhen Hospital (CN), China National Health Development Research Center (CN), China XD Group (China) (CN), Beijing Chaoyang Emergency Medical Center (CN)